1.
The Korean Journal of Laboratory Medicine
;
: 19-21, 2007.
Artículo
en Coreano
| WPRIM
| ID: wpr-35592
RESUMEN
The inv(16)(p13q22) is found in de novo AML and is closely associated with the FAB subtype M4eo. The inv(16) is rarely reported in therapy-related AML (t-AML) patients. Herein, we report a case of t-AML with inv(16) after combination chemotherapy using antimitotic agent and alkylating agent (cis-platin-paclitaxel) for ovarian serous cystadenocarcinoma.